HSBC scales back UK's investment banking arm as it looks to 'simplify' the business
Boss Georges Elhedery (pictured) is pressing ahead with an overhaul of the Asia-focused bank including a geographic split ...
Jim Cramer Connects Arm Holdings (ARM) to Stargate AI Buzz – Here’s Why
We recently published a list of Jim Cramer Discussed These 12 Stocks & Elon Musk Vs Sam Altman. In this article, we are going ...
HSBC to shut UK investment banking arm as part of major global restructuring
HSBC is set to wind down parts of its investment banking operations across the UK, Europe and North America as part of a ...
P/E Ratio Insights for ARM Holdings
Compared to the aggregate P/E ratio of 45.57 in the Semiconductors & Semiconductor Equipment industry, ARM Holdings Inc. has ...
cambridgeindependent14h
Cambridge AI expert says DeepSeek furore hit on Arm share value ‘a wake-up call’
US President Donald Trump is already calling the DeepSeek approach a “wake-up call” for American AI giants. Nvidia, the world ...
Arm Holdings plc (ARM): AI Boom Fuels Market Dominance and Stock Surge
We recently compiled a list of the 35 Most Important AI Stocks for 2025 According to JPMorgan. In this article, we are going ...
Arm Holdings: Robust Growth Prospects Don't Warrant Triple Digits PE Valuations
Discover why ARM's growth prospects in data centers, CPUs, smartphones, and automotive tech are promising, despite its high ...
2 Unstoppable Growth Stocks for 2025 and Beyond
Arm Holdings (NASDAQ: ARM) and Reddit (NYSE: RDDT) are certainly pricey, but both have unique advantages that bode well for ...
Jim Cramer on Arm Holdings plc (ARM): ‘When You Think About Arm, These Are All Ancillary Plays That Are Making Fortunes’
We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In ...
Arm Holdings’ (ARM) $140 Price Target: A Signal to Buy or Stay Neutral?
We recently published a list of 10 AI News You Should Definitely Take a Look At. In this article, we are going to take a look ...
Cancer Therapy Advisor3d
Camrelizumab and Rivoceranib Improve Upon TACE in Unresectable HCC
Adding camrelizumab and rivoceranib to TACE improved PFS in patients with unresectable HCC in a phase 2 trial.
Stocks to Watch: Richardson Electronics, Tevogen Bio Holdings
Tevogen Bio Holdings expanded its artificial-intelligence partnership with Microsoft. The immunotherapy biotech company said its AI effort, Tevogen.AI, will integrate Microsoft's advanced AI tools and ...